| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.002 |